| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
American Society of Clinical Oncology 2013 annual meeting update: Summary of selected gynecologic oncology abstracts
|
Seamon, Leigh G.
|
|
2013
|
130 |
2 |
p. 257-263
7 p.
|
artikel
|
| 2 |
Are supportive care-based treatment strategies preferable to standard chemotherapy in recurrent cervical cancer?
|
Phippen, Neil T.
|
|
2013
|
130 |
2 |
p. 317-322
6 p.
|
artikel
|
| 3 |
Differentiating stage I epithelial ovarian cancer from benign disease in women with adnexal tumors using biomarkers or the ROMA algorithm
|
Kaijser, J.
|
|
2013
|
130 |
2 |
p. 398-399
2 p.
|
artikel
|
| 4 |
Differentiating stage I epithelial ovarian cancer from benign disease in women with adnexal tumours using biomarkers or the ROMA algorithm
|
Kondalsamy-Chennakesavan, S.
|
|
2013
|
130 |
2 |
p. 400-
1 p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
2013
|
130 |
2 |
p. i-
1 p.
|
artikel
|
| 6 |
Endometrial cancer and a family history of cancer
|
Cook, Linda S.
|
|
2013
|
130 |
2 |
p. 334-339
6 p.
|
artikel
|
| 7 |
Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase
|
Hartkopf, A.D.
|
|
2013
|
130 |
2 |
p. 362-368
7 p.
|
artikel
|
| 8 |
Evaluation of exposures to healthcare personnel from cisplatin during a mock demonstration of intra-operative intraperitoneal chemotherapy administration
|
Kushnir, Christina L.
|
|
2013
|
130 |
2 |
p. 350-353
4 p.
|
artikel
|
| 9 |
HPV vaccination in women treated for CIN2/3: It's still all about prevention
|
Huh, Warner K.
|
|
2013
|
130 |
2 |
p. 255-256
2 p.
|
artikel
|
| 10 |
Involved-field radiation therapy for locoregionally recurrent ovarian cancer
|
Brown, Aaron P.
|
|
2013
|
130 |
2 |
p. 300-305
6 p.
|
artikel
|
| 11 |
Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2–3)?
|
Kang, Woo Dae
|
|
2013
|
130 |
2 |
p. 264-268
5 p.
|
artikel
|
| 12 |
Keeping it simple: Genetics referrals for all invasive serous ovarian cancers
|
Demsky, R.
|
|
2013
|
130 |
2 |
p. 329-333
5 p.
|
artikel
|
| 13 |
Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis
|
Lum, Elena
|
|
2013
|
130 |
2 |
p. 369-376
8 p.
|
artikel
|
| 14 |
Optimal (≤1cm) but visible residual disease: Is extensive debulking warranted?
|
Barlin, J.N.
|
|
2013
|
130 |
2 |
p. 284-288
5 p.
|
artikel
|
| 15 |
Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)
|
Tinker, A.V.
|
|
2013
|
130 |
2 |
p. 269-274
6 p.
|
artikel
|
| 16 |
Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia
|
Maestá, Izildinha
|
|
2013
|
130 |
2 |
p. 312-316
5 p.
|
artikel
|
| 17 |
Recurrence patterns after extended treatment with bevacizumab for ovarian, fallopian tube, and primary peritoneal cancers
|
Dao, Minh D.
|
|
2013
|
130 |
2 |
p. 295-299
5 p.
|
artikel
|
| 18 |
Risk of second primary cancer among women with breast cancer: A population-based study in Granada (Spain)
|
Molina-Montes, Esther
|
|
2013
|
130 |
2 |
p. 340-345
6 p.
|
artikel
|
| 19 |
Survivorship planning in gynecologic cancer patients
|
Salani, Ritu
|
|
2013
|
130 |
2 |
p. 389-397
9 p.
|
artikel
|
| 20 |
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: The role of 18F-FDG PET/CT
|
Crivellaro, Cinzia
|
|
2013
|
130 |
2 |
p. 306-311
6 p.
|
artikel
|
| 21 |
The Patient Protection and Affordable Care Act: Impact on the care of gynecologic oncology patients in the absence of Medicaid expansion in Central Virginia
|
Courtney-Brooks, Madeleine
|
|
2013
|
130 |
2 |
p. 346-349
4 p.
|
artikel
|
| 22 |
The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer
|
Moxley, K.M.
|
|
2013
|
130 |
2 |
p. 377-382
6 p.
|
artikel
|
| 23 |
The strong prognostic value of KELIM, a model-based parameter from CA 125 kinetics in ovarian cancer: Data from CALYPSO trial (a GINECO-GCIG study)
|
You, Benoit
|
|
2013
|
130 |
2 |
p. 289-294
6 p.
|
artikel
|
| 24 |
The use of CT findings to predict extent of tumor at primary surgery for ovarian cancer
|
Glaser, Gretchen
|
|
2013
|
130 |
2 |
p. 280-283
4 p.
|
artikel
|
| 25 |
The utility of PAX8 and IMP3 immunohistochemical stains in the differential diagnosis of benign, premalignant, and malignant endocervical glandular lesions
|
Danialan, Richard
|
|
2013
|
130 |
2 |
p. 383-388
6 p.
|
artikel
|
| 26 |
Total laparoscopic radical trachelectomy in the treatment of early squamous cell cervical cancer: A retrospective study with 8-year follow-up
|
Lu, Qi
|
|
2013
|
130 |
2 |
p. 275-279
5 p.
|
artikel
|
| 27 |
Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer
|
Sailors, Mary H.
|
|
2013
|
130 |
2 |
p. 323-328
6 p.
|
artikel
|
| 28 |
WAVE1 gene silencing via RNA interference reduces ovarian cancer cell invasion, migration and proliferation
|
Zhang, Jing
|
|
2013
|
130 |
2 |
p. 354-361
8 p.
|
artikel
|
Tijdschrift beschrijving